Skip to main content

Halving the TKI dose safe, cost effective in CML patients with stable remissions

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Halving the TKI dose safe, cost effective in CML patients with stable remissions

User login

Username

Password

Reset your password

Type	Lead	score